358 related articles for article (PubMed ID: 20453196)
1. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.
Ahmadiyeh N; Pomerantz MM; Grisanzio C; Herman P; Jia L; Almendro V; He HH; Brown M; Liu XS; Davis M; Caswell JL; Beckwith CA; Hills A; Macconaill L; Coetzee GA; Regan MM; Freedman ML
Proc Natl Acad Sci U S A; 2010 May; 107(21):9742-6. PubMed ID: 20453196
[TBL] [Abstract][Full Text] [Related]
2. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus.
Xiang JF; Yin QF; Chen T; Zhang Y; Zhang XO; Wu Z; Zhang S; Wang HB; Ge J; Lu X; Yang L; Chen LL
Cell Res; 2014 May; 24(5):513-31. PubMed ID: 24662484
[TBL] [Abstract][Full Text] [Related]
3. Long-range enhancers on 8q24 regulate c-Myc.
Sotelo J; Esposito D; Duhagon MA; Banfield K; Mehalko J; Liao H; Stephens RM; Harris TJ; Munroe DJ; Wu X
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3001-5. PubMed ID: 20133699
[TBL] [Abstract][Full Text] [Related]
4. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
5. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
Wasserman NF; Aneas I; Nobrega MA
Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
[TBL] [Abstract][Full Text] [Related]
6. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
Ling H; Spizzo R; Atlasi Y; Nicoloso M; Shimizu M; Redis RS; Nishida N; Gafà R; Song J; Guo Z; Ivan C; Barbarotto E; De Vries I; Zhang X; Ferracin M; Churchman M; van Galen JF; Beverloo BH; Shariati M; Haderk F; Estecio MR; Garcia-Manero G; Patijn GA; Gotley DC; Bhardwaj V; Shureiqi I; Sen S; Multani AS; Welsh J; Yamamoto K; Taniguchi I; Song MA; Gallinger S; Casey G; Thibodeau SN; Le Marchand L; Tiirikainen M; Mani SA; Zhang W; Davuluri RV; Mimori K; Mori M; Sieuwerts AM; Martens JW; Tomlinson I; Negrini M; Berindan-Neagoe I; Foekens JA; Hamilton SR; Lanza G; Kopetz S; Fodde R; Calin GA
Genome Res; 2013 Sep; 23(9):1446-61. PubMed ID: 23796952
[TBL] [Abstract][Full Text] [Related]
7. Insights into the Links between MYC and 3D Chromatin Structure and Epigenetics Regulation: Implications for Cancer Therapy.
Amjadi-Moheb F; Paniri A; Akhavan-Niaki H
Cancer Res; 2021 Apr; 81(8):1925-1936. PubMed ID: 33472888
[No Abstract] [Full Text] [Related]
8. Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome.
Du M; Yuan T; Schilter KF; Dittmar RL; Mackinnon A; Huang X; Tschannen M; Worthey E; Jacob H; Xia S; Gao J; Tillmans L; Lu Y; Liu P; Thibodeau SN; Wang L
Hum Mol Genet; 2015 Jan; 24(1):154-66. PubMed ID: 25149474
[TBL] [Abstract][Full Text] [Related]
9. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue.
Prokunina-Olsson L; Hall JL
Mol Cancer; 2009 Nov; 8():96. PubMed ID: 19895682
[TBL] [Abstract][Full Text] [Related]
10. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.
Guan Y; Kuo WL; Stilwell JL; Takano H; Lapuk AV; Fridlyand J; Mao JH; Yu M; Miller MA; Santos JL; Kalloger SE; Carlson JW; Ginzinger DG; Celniker SE; Mills GB; Huntsman DG; Gray JW
Clin Cancer Res; 2007 Oct; 13(19):5745-55. PubMed ID: 17908964
[TBL] [Abstract][Full Text] [Related]
11. Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region upregulating the allele-specific MYC expression in HeLa cells.
Shen C; Liu Y; Shi S; Zhang R; Zhang T; Xu Q; Zhu P; Chen X; Lu F
Int J Cancer; 2017 Aug; 141(3):540-548. PubMed ID: 28470669
[TBL] [Abstract][Full Text] [Related]
12. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
Pomerantz MM; Ahmadiyeh N; Jia L; Herman P; Verzi MP; Doddapaneni H; Beckwith CA; Chan JA; Hills A; Davis M; Yao K; Kehoe SM; Lenz HJ; Haiman CA; Yan C; Henderson BE; Frenkel B; Barretina J; Bass A; Tabernero J; Baselga J; Regan MM; Manak JR; Shivdasani R; Coetzee GA; Freedman ML
Nat Genet; 2009 Aug; 41(8):882-4. PubMed ID: 19561607
[TBL] [Abstract][Full Text] [Related]
13. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.
Poli V; Fagnocchi L; Fasciani A; Cherubini A; Mazzoleni S; Ferrillo S; Miluzio A; Gaudioso G; Vaira V; Turdo A; Gaggianesi M; Chinnici A; Lipari E; Bicciato S; Bosari S; Todaro M; Zippo A
Nat Commun; 2018 Mar; 9(1):1024. PubMed ID: 29523784
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
Wright JB; Brown SJ; Cole MD
Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
[TBL] [Abstract][Full Text] [Related]
15. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
Pomerantz MM; Beckwith CA; Regan MM; Wyman SK; Petrovics G; Chen Y; Hawksworth DJ; Schumacher FR; Mucci L; Penney KL; Stampfer MJ; Chan JA; Ardlie KG; Fritz BR; Parkin RK; Lin DW; Dyke M; Herman P; Lee S; Oh WK; Kantoff PW; Tewari M; McLeod DG; Srivastava S; Freedman ML
Cancer Res; 2009 Jul; 69(13):5568-74. PubMed ID: 19549893
[TBL] [Abstract][Full Text] [Related]
17. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
18. Mice deficient of
Dave K; Sur I; Yan J; Zhang J; Kaasinen E; Zhong F; Blaas L; Li X; Kharazi S; Gustafsson C; De Paepe A; Månsson R; Taipale J
Elife; 2017 Jun; 6():. PubMed ID: 28583252
[TBL] [Abstract][Full Text] [Related]
19. 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus.
Cai M; Kim S; Wang K; Farnham PJ; Coetzee GA; Lu W
Sci Rep; 2016 Mar; 6():22462. PubMed ID: 26934861
[TBL] [Abstract][Full Text] [Related]
20. The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert.
Gu Y; Lin X; Kapoor A; Chow MJ; Jiang Y; Zhao K; Tang D
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
